[Incidence, prevention and therapy of acute mountain sickness]
- PMID: 7079685
[Incidence, prevention and therapy of acute mountain sickness]
Abstract
The symptoms and signs of acute mountain sickness are present in about half of the tourists trekking in Nepal to an altitude of 42000 m. The most common symptoms are headache and nausea. Pulmonary rales are found in more than 10% of trekkers, while high altitude pulmonary edema is rare. Retinal hemorrhages occur almost exclusively above 5000 m. A careful history and physical examination are generally sufficient for medical evaluation of fitness for high altitude. There are no specific tests to predict performance at altitude. The most effective prophylaxis of acute mountain sickness is "slow" ascent, which is arbitrarily defined as an increase in sleeping altitude of 300-400 m per 24 hours. Sufficient fluid intake is also very important. Prophylactic administration of acetazolamide reduces the incidence and severity of acute mountain sickness. Mild forms of acute mountain sickness are treated by a rest day, whereas patients with severe disease should descend as soon as possible.
Similar articles
-
[Mountaineering and altitude sickness].Ther Umsch. 2001 Jun;58(6):387-93. doi: 10.1024/0040-5930.58.6.387. Ther Umsch. 2001. PMID: 11441701 Review. German.
-
Alpine travel. Mountain sickness, the unwelcome companion.Med J Aust. 1984 Dec 8-22;141(12-13):792-5. Med J Aust. 1984. PMID: 6503782
-
High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema.Expert Opin Pharmacother. 2008 Jan;9(1):119-27. doi: 10.1517/14656566.9.1.119. Expert Opin Pharmacother. 2008. PMID: 18076343 Review.
-
Rales, peripheral edema, retinal hemorrhage and acute mountain sickness.Am J Med. 1979 Aug;67(2):214-8. doi: 10.1016/0002-9343(79)90393-0. Am J Med. 1979. PMID: 463925 No abstract available.
-
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).BMJ. 2004 Apr 3;328(7443):797. doi: 10.1136/bmj.38043.501690.7C. Epub 2004 Mar 11. BMJ. 2004. PMID: 15070635 Free PMC article. Clinical Trial.